62 related articles for article (PubMed ID: 21338577)
1. Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.
Song MH; Ha JC; Lee SM; Park YM; Lee SY
Biochem Biophys Res Commun; 2011 May; 408(2):195-201. PubMed ID: 21338577
[TBL] [Abstract][Full Text] [Related]
2. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
[TBL] [Abstract][Full Text] [Related]
3. Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer.
Kim YR; Kim KU; Lee JH; Kim DW; Chung JH; Kim YD; Shin DH; Lee MK; Shin YI; Lee SY
Curr Oncol; 2021 May; 28(3):1927-1937. PubMed ID: 34065612
[TBL] [Abstract][Full Text] [Related]
4. Significance of cancer testis-associated antigens (
Ramadan RA; Morsy H; Samir M; Shamseya M; Shalaby M; El-Attar EA
Indian J Cancer; 2022; 59(3):394-401. PubMed ID: 34380828
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumour antigens by serological analysis of cDNA expression cloning.
Li G; Miles A; Line A; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of tumour-associated antigens in colon cancer.
Line A; Slucka Z; Stengrevics A; Silina K; Li G; Rees RC
Cancer Immunol Immunother; 2002 Nov; 51(10):574-82. PubMed ID: 12384809
[TBL] [Abstract][Full Text] [Related]
7. Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection.
Kostianets O; Shyyan M; Antoniuk SV; Filonenko V; Kiyamova R
Biomarkers; 2017 Mar; 22(2):149-156. PubMed ID: 27775439
[TBL] [Abstract][Full Text] [Related]
8. Serological identification and bioinformatics analysis of immunogenic antigens in multiple myeloma.
Zhou FL; Zhang WG; Chen G; Zhao WH; Cao XM; Chen YX; Tian W; Liu J; Liu SH
Cancer Immunol Immunother; 2006 Aug; 55(8):910-7. PubMed ID: 16193335
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning.
Jäger D; Taverna C; Zippelius A; Knuth A
Cancer Immunol Immunother; 2004 Mar; 53(3):144-7. PubMed ID: 14727084
[TBL] [Abstract][Full Text] [Related]
10. Immunological and functional aspects of MAGEA3 cancer/testis antigen.
Das B; Senapati S
Adv Protein Chem Struct Biol; 2021; 125():121-147. PubMed ID: 33931137
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor antigens in malignant mesothelioma.
Kim YR; Song MH; Lee JW; Bae JH; Kim JE; Kang DM; Lee SY
Oncol Lett; 2017 Oct; 14(4):4557-4562. PubMed ID: 29085453
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
Siebenkäs C; Chiappinelli KB; Guzzetta AA; Sharma A; Jeschke J; Vatapalli R; Baylin SB; Ahuja N
PLoS One; 2017; 12(6):e0179501. PubMed ID: 28622390
[TBL] [Abstract][Full Text] [Related]
13. Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library.
Kobayashi S; Hiwasa T; Arasawa T; Kagaya A; Ishii S; Shimada H; Ito M; Suzuki M; Kano M; Rahmutulla B; Kitamura K; Sawabe Y; Shin H; Takiguchi M; Nomura F; Matsubara H; Matsushita K
Oncotarget; 2018 Apr; 9(26):18559-18569. PubMed ID: 29719626
[TBL] [Abstract][Full Text] [Related]
14. Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn's-like Lymphoid Reaction.
Boncheva VB; Linnebacher M; Kdimati S; Draper H; Orchard L; Mills KI; O'Sullivan G; Tangney M; Guinn BA
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008952
[TBL] [Abstract][Full Text] [Related]
15. Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update.
Mooney SM; Rajagopalan K; Rangarajan G; Kulkarni P
Asian J Androl; 2016; 18(5):711-2. PubMed ID: 26908068
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.
Li X; Yan J; Fan R; Luo B; Zhang Q; Lin Y; Zhou S; Luo G; Xie X; Xiao S
Oncol Lett; 2017 May; 13(5):3080-3086. PubMed ID: 28529561
[TBL] [Abstract][Full Text] [Related]
17. Cancer testis antigen expression across T-cell lymphoma subtypes.
Ma H; Soderquist CR; Marchi E; Scotto L; Bhagat G; O'Connor OA
Hematol Oncol; 2020 Dec; 38(5):827-830. PubMed ID: 32744349
[No Abstract] [Full Text] [Related]
18. [Current Standard Diagnosis and Treatment of Colon Cancer].
Lordick F; Mössner J
Dtsch Med Wochenschr; 2017 Apr; 142(7):487-490. PubMed ID: 28388743
[No Abstract] [Full Text] [Related]
19. Immunotherapy: genetically agnostic in BCP-ALL?
Zwaan CM; Calkoen FGJ
Blood; 2022 Apr; 139(14):2093-2094. PubMed ID: 35389440
[No Abstract] [Full Text] [Related]
20. Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers.
Ai H; Yang H; Li L; Ma J; Liu K; Li Z
Front Immunol; 2023; 14():1190883. PubMed ID: 37398650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
